Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYANOTECH CORPCYAN · Entity 8431 | Chief Scientific Officer | July 29, 2025 | July 31, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYANOTECH CORP
Report date July 29, 2025 · Filed July 31, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 146,697 |
Ending reported balance
After 2025-07-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-07-29 · Exercise / conversion · Acquired 1,577 · Balance 147,289 F1: Represents the conversion upon vesting of restricted stock units into common stock. Row 2 · 2025-07-29 · Tax withholding · Disposed 592 · Balance 146,697 F2: No stock was sold. On July 29, 2025, in connection with the vesting of 1,577 shares of stock, the Company withheld a total of 592 shares to satisfy a payroll tax liability incident to such vesting. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 34 |
Reported balance
After 2025-07-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-07-29 · Exercise / conversion · Disposed 1,577 · Balance 34 F3: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4: The restricted stock units vest as to 34 shares on April 6, 2026, and is subject to the reporting person's continued service with the Company on the vesting date. |
| Common StockSEC Table I · non-derivative | IndirectHeld by spouse | 250 |
Reported balance
Holding disclosure · report date 2025-07-29 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 250 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion upon vesting of restricted stock units into common stock.
F2: No stock was sold. On July 29, 2025, in connection with the vesting of 1,577 shares of stock, the Company withheld a total of 592 shares to satisfy a payroll tax liability incident to such vesting.
F3: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock.
F4: The restricted stock units vest as to 34 shares on April 6, 2026, and is subject to the reporting person's continued service with the Company on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2025 Filed Jul 31, 2025 13:25 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 1,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-024122 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34 Underlying: Common Stock · 1,577 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2026, and is subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2026, and is subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 13:25 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 592 | $0.41 | $239.76 |
DisclosureSEC source: 0001437749-25-024122 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,697 F2 · kind: No stock was sold. On July 29, 2025, in connection with the vesting of 1,577 shares of stock, the Company withheld a total of 592 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 13:25 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 1,577 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-024122 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 15:51 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-011512 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,611 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 15:51 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 13 | $0.31 | $4.03 |
DisclosureSEC source: 0001437749-25-011512 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,712 F2 · kind: No stock was sold. On April 7, 2025, in connection with the vesting of 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 15:51 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-011512 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 14:50 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-004537 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,644 Underlying: Common Stock · 3,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 14:50 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 1,464 | $0.40 | $585.60 |
DisclosureSEC source: 0001437749-25-004537 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,692 F2 · kind: No stock was sold. On February 18, 2025, in connection with the vesting of 3900 shares of stock, the Company withheld a total of 1,464 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 14:50 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-004537 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 16:04 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 1,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-024101 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,544 Underlying: Common Stock · 1,576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 3,900 shares on February 16, 2025; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 3,900 shares on February 16, 2025; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 16:04 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 592 | $0.56 | $331.52 |
DisclosureSEC source: 0001437749-24-024101 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,256 F2 · kind: No stock was sold. On July 29, 2024, in connection with the vesting of 1576 shares of stock, the Company withheld a total of 592 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 29, 2024 Filed Jul 31, 2024 16:04 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 1,576 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-024101 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 08, 2024 Filed Apr 10, 2024 18:15 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-011674 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,120 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 1,576 shares on July 29, 2024; 3,900 shares on February 16, 2025; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 1,576 shares on July 29, 2024; 3,900 shares on February 16, 2025; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 08, 2024 Filed Apr 10, 2024 18:15 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 13 | $0.40 | $5.20 |
DisclosureSEC source: 0001437749-24-011674 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,272 F2 · kind: No stock was sold. On April 8, 2024, in connection with the vesting of 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 08, 2024 Filed Apr 10, 2024 18:15 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-011674 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 10:46 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004959 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,153 Underlying: Common Stock · 3,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 3,900 shares on February 16, 2025; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 3,900 shares on February 16, 2025; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 10:46 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 1,465 | $0.44 | $644.60 |
DisclosureSEC source: 0001437749-24-004959 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,252 F2 · kind: No stock was sold. On February 16, 2024, in connection with the vesting of 3,900 shares of stock, the Company withheld a total of 1,465 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 10:46 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-004959 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:04 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 2,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021368 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,253 Underlying: Common Stock · 2,243 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:04 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 843 | $0.84 | $708.12 |
DisclosureSEC source: 0001437749-23-021368 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,817 F2 · kind: No stock was sold. On July 31, 2023, in connection with the vesting of 2,243 shares of stock, the Company withheld a total of 843 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 15:04 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 2,243 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-021368 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,660 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:52 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009811 · rdgdoc.xml · derivative · entry 5 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,496 Underlying: Common Stock · 34 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:52 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009811 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,530 Underlying: Common Stock · 100 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 33 shares on April 6, 2024; 1,576 shares on July 29, 2024; 33 shares on April 6, 2025; 1,577 shares on July 29, 2025; and 34 shares on April 6, 2026, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:52 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 13 | $0.94 | $12.22 |
DisclosureSEC source: 0001437749-23-009811 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,417 F2 · kind: No stock was sold. On April 6, 2023, in connection with the vesting of 34 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 14:52 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-009811 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:53 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018400 · rdgdoc.xml · derivative · entry 5 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,430 Underlying: Common Stock · 666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F5 · derivative.exercise_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 1,576 shares on July 29, 2024; and 1,577 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 1,576 shares on July 29, 2024; and 1,577 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:53 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 251 | $3.15 | $790.65 |
DisclosureSEC source: 0001437749-22-018400 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,396 F2 · kind: No stock was sold. On August 1, 2022, in connection with the vesting of 666 shares of stock, the Company withheld a total of 251 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 15:53 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018400 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,647 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 15:53 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted Stock Units · Derivative | 4,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-018400 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,096 Underlying: Common Stock · 4,729 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 666 shares on July 30, 2022; 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 1,576 shares on July 29, 2024; and 1,577 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 666 shares on July 30, 2022; 34 shares on April 6, 2023; 1,576 shares on July 29, 2023; 667 shares on July 30, 2023; 1,576 shares on July 29, 2024; and 1,577 shares on July 29, 2025, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:18 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008576 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:18 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 13 | $3.03 | $39.39 |
DisclosureSEC source: 0001437749-22-008576 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,981 F2 · kind: No stock was sold. On April 6, 2022, in connection with the vesting of 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 15:18 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-008576 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 18:41 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-018398 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock · 666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 18:41 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 251 | $3.06 | $768.06 |
DisclosureSEC source: 0001437749-21-018398 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,961 F2 · kind: No stock was sold. On July 30, 2021, in connection with the vesting of 666 shares of stock, the Company withheld a total of 251 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 18:41 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-018398 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 21:02 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 736 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-017017 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,066 Underlying: Common Stock · 736 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 21:02 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 277 | $2.99 | $828.23 |
DisclosureSEC source: 0001437749-21-017017 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,546 F2 · kind: No stock was sold. On July 13, 2021, in connection with the vesting of 736 shares of stock, the Company withheld a total of 277 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 13, 2021 Filed Jul 15, 2021 21:02 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 736 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-017017 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:29 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-008562 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,802 Underlying: Common Stock · 33 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 736 shares on July 13, 2021; 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 736 shares on July 13, 2021; 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:29 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 13 | $3.35 | $43.55 |
DisclosureSEC source: 0001437749-21-008562 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,087 F2 · kind: No stock was sold. On April 6, 2021, in connection with the vesting of 33 shares of stock, the Company withheld a total of 13 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2021 Filed Apr 8, 2021 16:29 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 33 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-008562 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 17:07 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted Stock Units · Derivative | 1,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-016330 · rdgdoc.xml · derivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,835 Underlying: Common Stock · 1,999 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F2 · derivative.exercise_date: The restricted stock units vest as to 33 shares on April 6, 2021; 736 shares on July 13, 2021; 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F2 · derivative.expiration_date: The restricted stock units vest as to 33 shares on April 6, 2021; 736 shares on July 13, 2021; 666 shares on July 30, 2021; 33 shares on April 6, 2022; 666 shares on July 30, 2022; 34 shares on April 6, 2023; and 667 shares on July 30, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 18:58 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionRestricted Stock Units · Derivative | 737 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015216 · rdgdoc.xml · derivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 836 Underlying: Common Stock · 737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 736 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units shall vest as to 33 shares on April 6, 2021; 736 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 18:58 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 277 | $2.25 | $623.25 |
DisclosureSEC source: 0001437749-20-015216 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,067 F2 · kind: No stock was sold. On July 13, 2020, in connection with the vesting of 737 shares of stock, the Company withheld a total of 277 shares to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| July 13, 2020 Filed Jul 15, 2020 18:58 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 737 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-015216 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:18 UTC | CYANOTECH CORP CYAN · Entity 8431 | GrantRestricted Stock Units · Derivative | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · derivative · entry 6 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,573 Underlying: Common Stock · 1,573 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one (1) share of Cyanotech Common Stock. F4 · derivative.exercise_date: The restricted stock units vest as to 737 shares on July 13, 2020; 33 shares on April 6, 2021; 736 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. F4 · derivative.expiration_date: The restricted stock units vest as to 737 shares on July 13, 2020; 33 shares on April 6, 2021; 736 shares on July 13, 2021; 33 shares on April 6, 2022; and 34 shares on April 6, 2023, in each case subject to the reporting person's continued service with the Company on the vesting date. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:18 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 63 | $2.07 | $130.41 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · nonDerivative · entry 4 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,607 F2 · kind: No stock was sold. On March 31, 2020 and April 6, 2020, in connection with the vesting of 8,334 and 166 shares of stock, respectively, the Company withheld a total of 3,130 and 63 shares, respectively, to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| April 06, 2020 Filed Apr 8, 2020 18:18 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · nonDerivative · entry 3 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
| March 31, 2020 Filed Apr 8, 2020 18:18 UTC | CYANOTECH CORP CYAN · Entity 8431 | Tax withholdingCommon Stock | 3,130 | $2.06 | $6,447.80 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · nonDerivative · entry 2 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,504 F2 · kind: No stock was sold. On March 31, 2020 and April 6, 2020, in connection with the vesting of 8,334 and 166 shares of stock, respectively, the Company withheld a total of 3,130 and 63 shares, respectively, to satisfy a payroll tax liability incident to such vesting. Read SEC document |
| March 31, 2020 Filed Apr 8, 2020 18:18 UTC | CYANOTECH CORP CYAN · Entity 8431 | Exercise / conversionCommon Stock | 8,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-007344 · rdgdoc.xml · nonDerivative · entry 1 Cysewski Gerald R · CIK 0001369133 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units into common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.